543904:BOM
Mankind Pharma Ltd
2.399,00 ₹
arrow_upward
+1,27%(+30,00) 1d
12 d’oct., 15:30:00 GMT+5:30 · INR
search
Tots els símbols
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a 543904...
Obre
2.359,25 ₹
Alt
2.425,05 ₹
Baix
2.359,25 ₹
Capitalització borsària
988,49 kM
Volum mitjà
40,18 k
Volum
9,03 k
Ràtio preu-benefici
48,54
Alt 52 setmanes
2.640,30 ₹
Baix 52 setmanes
1.909,90 ₹
BPA
49,42 ₹
Nombre d'empleats
20 k
Obre
2.359,25 ₹
Alt
2.425,05 ₹
Baix
2.359,25 ₹
Capitalització borsària
988,49 kM
Volum mitjà
40,18 k
Volum
9,03 k
Ràtio preu-benefici
48,54
Alt 52 setmanes
2.640,30 ₹
Baix 52 setmanes
1.909,90 ₹
BPA
49,42 ₹
Nombre d'empleats
20 k
Notícies
De fonts web i partners de notícies
TipRanks
·
fa 15 hores
Mankind Pharma Sets Earnings Call for Q2 and H1 FY27
Perfil
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Sobre Mankind Pharma Ltd
Conseller delegatRajeev Juneja | Sheetal Arora
Empleats20,5 k
Fundació1991
Seu principal-
Sector-
Lloc webmankindpharma.com